Category: Neurosciences & Behavioral Health

Focused Ultrasound Shows Promise Against Deadliest Brain Tumor

June 22, 2020
Focused ultrasound waves create tiny bubbles inside cancer cells, causing them to die.

New Stroke Guidelines Aim to Improve Care Amid COVID-19

May 28, 2020
Top stroke experts have issued new guidance to ensure stroke patients receive safe, timely care while preventing the transmission of COVID-19.

Team-Up Targets Spinal Cord Injuries

April 29, 2020
Two top scientists are seeking answers to questions about spinal cord injuries that have long frustrated the development of effective treatments.

Brain Discovery Suggests Source of Lifelong Behavioral Issues

April 8, 2020
The brain finding also could have important implications for a wide range of neurodegenerative diseases, such as Alzheimer’s and Parkinson’s.

UVA Wins National Award for Neurosurgery and Spine Care

February 13, 2020

For the sixth consecutive year, UVA Medical Center has been honored by Becker’s Hospital Review in its… read more >

233 UVA Physicians Selected for Best Doctors in America® List

November 19, 2019

233 UVA Health physicians have been named by their peers to the 2019-2020 Best Doctors in America®List…. read more >

UVA Leads Major Effort to Understand Autism Differences in Boys, Girls

August 12, 2019
The lack of information about autism’s manifestation in girls means many are never diagnosed and miss out on beneficial interventions, UVA's Kevin Pelphrey fears.

U.S. News & World Report Ranks UVA as No. 1 Hospital in Virginia

July 30, 2019
U.S. News & World Report has ranked University of Virginia Medical Center as the No. 1 hospital in Virginia for the fourth consecutive year.

Doctors Determine How to Handle Blood Sugar After Stroke

July 23, 2019
Aggressive management of blood sugar levels after stroke is no better than standard approaches, a landmark study led by UVA found.

Can an Investigational Drug Delivered in the Ambulance Improve Stroke Outcomes?

July 1, 2019
UVA Health is launching a clinical trial with local emergency service providers to determine whether an investigational new drug, trans sodium crocetinate (TSC), can improve patient outcomes when administered at the first signs of a stroke.